r.mensa
TL2 Moderator · Vaasa
Contributes reviews on supplier material. Based in Vaasa.
Joined 18 June 2025 · last posted 11d · groups: regional-apac
83 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 0 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #39 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 18 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #21 · Lounge › Off topic · 8 Jul 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #110 · Evidence › Journal club · 4 Jul 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a syringe in poor light, and how to avoid needing to Replied, post #2 · marked as the solution · Devices › Syringes & needles · 1 Jul 2026 · 12 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Asking a follow-up: new topic or new reply? Replied, post #18 · Start Here › How to Ask · 20 Jun 2026 · 21 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
External review after an internal denial Replied, post #3 · Access › Insurance & coverage · 16 Jun 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials…
-
A critique that turned out to be unfair, retracted by its author Replied, post #13 · Evidence › Study critique · 16 Jun 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Bias towards the null and bias away from the null: different criticisms have different directions.…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #84 · Access › Insurance & coverage · 11 Jun 2026 · 29 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
Prescription requirements and telehealth models — a second dataset Replied, post #58 · Sourcing › Regulatory · 8 Jun 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Time to steady state after a dose increase Replied, post #68 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 15 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #120 · Compounds › Tirzepatide · 3 Jun 2026 · 1 like SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #69 · Compounds › Semaglutide · 2 Jun 2026 · 3 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #4 · Evidence › Trials · 31 May 2026 · 4 likes Worth separating two things that post #2 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #73 · Evidence › Journal club · 25 May 2026 · 12 likes post #72 answers the question as asked. The question underneath it is different. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #19 · Analytics › Method validation · 12 May 2026 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #85 · Practice › Interactions · 13 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Official shortage notices and what they authorise Replied, post #5 · Access › Shortages · 12 Apr 2026 · 11 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Recording a dissent on a document rather than suppressing it Replied, post #11 · Documentation › Doc review · 12 Apr 2026 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #66 · Practice › Interactions · 28 Mar 2026 · 10 likes Coming back to post #64, because the follow-up matters more than the original answer. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Managing an unplanned gap in supply Replied, post #62 · Access › Shortages · 16 Mar 2026 · 2 likes This follows post #59 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #48 · Compounds › Repair & healing peptides · 12 Mar 2026 · 0 likes Picking up post #45: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #43 · Practice › Storage & stability · 17 Feb 2026 · 0 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Adsorption to container surfaces and to plastics Replied, post #18 · Pharmacology › Formulation chemistry · 12 Feb 2026 · 5 likes Picking up post #15: that is the part I would want checked first. Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry.…
-
The headache that turns out to be dehydration Replied, post #151 · Nutrition & Training › Hydration & electrolytes · 23 Jan 2026 · 0 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #3 · Practice › Reconstitution · 5 Jan 2026 · 8 likes On the opening post — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #66 · Wellbeing › Mental health · 22 Dec 2025 · 0 likes post #65 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Tracking a preprint to publication: a worked example Replied, post #102 · Evidence › Preprints · 10 Dec 2025 · 12 likes On post #98 — agreed on the reasoning, with one qualification. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
Reading an interaction checker output critically Replied, post #54 · Practice › Interactions · 29 Nov 2025 · 8 likes Picking up post #51: that is the part I would want checked first. Separation timing versus clinically important interaction: a separation timing inconvenience (taking…
-
High-resolution MS on aggregates and what it can see Replied, post #103 · Analytics › Mass spectrometry · 26 Oct 2025 · 3 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #12 · Compounds › Tirzepatide · 19 Oct 2025 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #5 · Compounds › Tirzepatide · 18 Oct 2025 · 4 likes post #4 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Comparing my trajectory with the trial curves, carefully Replied, post #63 · Outcomes › Progress reports · 18 Oct 2025 · 13 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #91 · Practice › Storage & stability · 11 Oct 2025 · 1 like I read post #89 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #70 · Practice › Storage & stability · 6 Oct 2025 · 25 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Documentation that appears only after payment Replied, post #39 · Sourcing › Red flags · 3 Oct 2025 · 29 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Adolescents: a distinct evidence base — one year on Replied, post #21 · Clinical › Special populations · 1 Oct 2025 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Insomnia at a dose step: reported experiences Replied, post #14 · Wellbeing › Sleep · 30 Sep 2025 · 2 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Needle changes between doses on a reusable pen Replied, post #38 · Devices › Pens & autoinjectors · 25 Sep 2025 · 1 like Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Hypertension improvement and when medication needs revisiting Replied, post #76 · Clinical › Comorbidities · 22 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Which panel is worth repeating and which is worth ignoring Replied, post #96 · Clinical › Bloodwork · 28 Aug 2025 · 18 likes Coming back to post #94, because the follow-up matters more than the original answer. TSH and free hormones: TSH is a reasonable screening test but does not tell you…
-
Foaming during reconstitution and whether it matters Replied, post #24 · Practice › Reconstitution · 21 Aug 2025 · 21 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #22 · Practice › Side effects · 7 Aug 2025 · 24 likes post #21 is right about the mechanism and I think understates the practical bit. Constipation: common, manageable, and frequently under-reported because it is not…
-
Triple agonism: additive, synergistic, or neither? Replied, post #76 · Compounds › Retatrutide · 6 Aug 2025 · 1 like On post #72 — agreed on the reasoning, with one qualification. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood…
-
What a documentation review can and cannot tell you Replied, post #62 · Sourcing › Independent verification · 6 Aug 2025 · 1 like Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #46 · Analytics › Home & field testing · 2 Aug 2025 · 0 likes Worth separating two things that post #42 runs together. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does…
-
Titles that describe the question, not the situation Replied, post #61 · Start Here › How to Ask · 1 Aug 2025 · 5 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Are there stupid questions here? A staff answer, at length Replied, post #23 · Start Here › Welcome · 29 Jul 2025 · 3 likes I read post #21 twice before replying, because I had assumed the opposite. There is no stupid-questions rule and no penalty for asking badly. The response to a poorly…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #21 · Analytics › HPLC & UHPLC · 20 Jul 2025 · 3 likes post #20 answers the question as asked. The question underneath it is different. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar…
-
Coming back to: When "no data" is the complete and final answer Replied, post #47 · Compounds › Other compounds · 16 Jul 2025 · 26 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #13 · Compounds › Repair & healing peptides · 27 Jun 2025 · 9 likes post #12 answers the question as asked. The question underneath it is different. BPC-157: the preclinical literature is extensive, mostly from a small number of…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #88 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 15 likes post #87 is right about the mechanism and I think understates the practical bit. Protein supplements: whey, casein, and plant-based protein powders can help hit targets…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #41 · Compounds › Oral incretins · 2 Jun 2025 · 15 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Pre-registering a personal experiment, seriously Replied, post #83 · Research Methods › N-of-1 designs · 1 Jun 2025 · 1 like When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #104 · Sourcing › Red flags · 31 May 2025 · 16 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #87 · Data & Tools › Calculators · 23 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #122 · Evidence › Journal club · 23 May 2025 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #8 · Sourcing › Regulatory · 20 May 2025 · 11 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #42 · Compounds › Retatrutide · 13 May 2025 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Residual solvents and scavengers: what is looked for Replied, post #22 · Analytics › Impurities & related substances · 10 May 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A well-designed study with a badly written abstract Replied, post #41 · Evidence › Study critique · 24 Apr 2025 · 32 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #79 · Evidence › Journal club · 21 Apr 2025 · 29 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #42 · Compounds › Tirzepatide · 20 Apr 2025 · 25 likes post #41 answers the question as asked. The question underneath it is different. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
Retatrutide dose escalation in the published trials Started this topic · Compounds › Retatrutide · 8 Mar 2025 · 3 likes Posting this under the heading it deserves: Retatrutide dose escalation in the published trials Everything below is what sits behind that. Session topic: SURPASS-2 ( N…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #15 · Documentation › Doc review · 8 Feb 2025 · 12 likes post #14 is right about the mechanism and I think understates the practical bit. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the…
-
Food effects on oral incretin absorption: what is documented Started this topic · Compounds › Oral incretins · 31 Jan 2025 · 10 likes On the subject in the title: Food effects on oral incretin absorption: what is documented Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #76 · Compounds › Other compounds · 29 Jan 2025 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Distinguishing a deletion sequence by mass alone Started this topic · Analytics › Mass spectrometry · 17 Jan 2025 · 2 likes Distinguishing a deletion sequence by mass alone Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity…
-
[2026 update] New subcategory: rationale and scope Replied, post #156 · Meta › Announcements · 17 Jan 2025 · 3 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #18 · Sourcing › Vendor reports · 30 Dec 2024 · 5 likes post #17 answers the question as asked. The question underneath it is different. What "verified" means on our pages: specific lots were independently measured on stated…
-
Building a sensible monitoring schedule with your prescriber Replied, post #34 · Clinical › Bloodwork · 19 Dec 2024 · 1 like Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Two sessions a week versus four: what the evidence supports Replied, post #24 · Nutrition & Training › Resistance training · 5 Dec 2024 · 10 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #4 · Access › Pricing · 3 Dec 2024 · 1 like Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #55 · Clinical › Special populations · 24 Nov 2024 · 19 likes Picking up post #52: that is the part I would want checked first. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #92 · Compounds › Repair & healing peptides · 19 Nov 2024 · 14 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Why I ask for the gradient before I discuss the number Replied, post #33 · Analytics › HPLC & UHPLC · 4 Nov 2024 · 2 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #16 · Compounds › Secretagogues & GH axis · 16 Oct 2024 · 2 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Requesting a page: what makes a good request — what changed since Replied, post #132 · Documentation › Wiki requests · 13 Oct 2024 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Identical chromatograms across two different lots Replied, post #29 · Sourcing › Red flags · 25 Sep 2024 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #48 · Clinical › Bloodwork · 22 Sep 2024 · 0 likes Picking up post #45: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Progressive overload when the scale is falling — one year on Replied, post #61 · Nutrition & Training › Resistance training · 16 Sep 2024 · 3 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Merging two pages that cover the same ground — the long version Replied, post #5 · Documentation › Wiki requests · 11 Sep 2024 · 30 likes This follows post #2 rather than contradicting it. Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #45 · Analytics › COA interpretation · 11 Aug 2024 · 0 likes On post #41 — agreed on the reasoning, with one qualification. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure…